The recommended dosage of QSYMIA in patients with mild renal impairment (CrCl greater or equal to 50 and less than 80 mL/min) is the same as the recommended dosage for patients with normal renal function
Maroudas, A., Stockwell, R
REDEFINE 1 (Phase 3a, NEJM 2025) Garvey et al., n=3,417, 68 weeks
Provides Reminders and Progress Tracking With its live cycle visualizer , the app lets you see estimated medication levels over time
Standard peptide formulations often face delivery limitationsthis formula is designed with an absorption-enhanced system to support efficient topical application
Open communication about side effects, weight loss progress, and your quality of life ensures your treatment plan evolves in ways backed by clinical evidence and your unique genetic and metabolic profile